|

Plasma DNA Methylation for Preoperative Classification of Renal Masses

RECRUITINGSponsored by RenJi Hospital
Actively Recruiting
SponsorRenJi Hospital
Started2026-09-01
Est. completion2027-03-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

METH-RENAL is a prospective observational diagnostic development and threshold-setting study in adults with a renal mass scheduled for partial or radical nephrectomy. Peripheral blood is collected before surgery, and postoperative histopathology serves as the reference standard. The study will develop and internally validate a plasma DNA methylation classifier and lock the final marker panel, algorithm, and positivity cut-off for a subsequent independent prospective multicenter validation study.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:1.Age 18 years or older. 2.A renal mass identified by computed tomography and/or magnetic resonance imaging.

3.Partial nephrectomy or radical nephrectomy planned as part of routine clinical care.

4.Preoperative peripheral blood collection feasible before surgery or other treatment of the index lesion.

5.Final postoperative histopathological diagnosis expected to be available. 6.Written informed consent provided.

\-

Exclusion Criteria:7.Systemic anticancer therapy, radiotherapy, local ablation, or surgery/pathological sampling of the index renal lesion before study blood collection.

8.Concurrent active malignancy requiring systemic treatment that, in the investigator's judgment, could materially interfere with interpretation of the methylation assay.

9.Severe acute infection or another uncontrolled systemic condition that could compromise biospecimen quality or study procedures.

10.Inadequate preoperative blood specimen or failure of prespecified analytical quality-control requirements.

11.No definitive pathological diagnosis of the index renal lesion. Any condition that, in the investigator's judgment, makes participation inappropriate.

\-

Conditions3

Benign Renal MassCancerRenal Cell Carcinoma

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.